Report Detail

Pharma & Healthcare COVID-19 Impact on Global Pain Management Drugs & Devices, Market Insights and Forecast to 2026

  • RnM4082240
  • |
  • 29 June, 2020
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Pain Management Drugs & Devices Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pain Management Drugs & Devices Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pain Management Drugs & Devices Market Size Growth Rate by Type
    • 1.4.2 Pharmaceuticals
    • 1.4.3 Devices
  • 1.5 Market by Application
    • 1.5.1 Global Pain Management Drugs & Devices Market Size Growth Rate by Application
    • 1.5.2 Burn Pain
    • 1.5.3 Cancer Pain
    • 1.5.4 Dental/Facial Pain
    • 1.5.5 Migraine Headache Pain
    • 1.5.6 Musculoskeletal Pain
    • 1.5.7 Neuropathic Pain
    • 1.5.8 Obstetrical Pain
  • 1.6 Coronavirus Disease 2019 (Covid-19): Pain Management Drugs & Devices Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Pain Management Drugs & Devices Industry
      • 1.6.1.1 Pain Management Drugs & Devices Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Pain Management Drugs & Devices Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Pain Management Drugs & Devices Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Pain Management Drugs & Devices Market Size Estimates and Forecasts
    • 2.1.1 Global Pain Management Drugs & Devices Revenue 2015-2026
    • 2.1.2 Global Pain Management Drugs & Devices Sales 2015-2026
  • 2.2 Pain Management Drugs & Devices Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Pain Management Drugs & Devices Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Pain Management Drugs & Devices Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pain Management Drugs & Devices Competitor Landscape by Players

  • 3.1 Pain Management Drugs & Devices Sales by Manufacturers
    • 3.1.1 Pain Management Drugs & Devices Sales by Manufacturers (2015-2020)
    • 3.1.2 Pain Management Drugs & Devices Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Pain Management Drugs & Devices Revenue by Manufacturers
    • 3.2.1 Pain Management Drugs & Devices Revenue by Manufacturers (2015-2020)
    • 3.2.2 Pain Management Drugs & Devices Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pain Management Drugs & Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pain Management Drugs & Devices Revenue in 2019
    • 3.2.5 Global Pain Management Drugs & Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Pain Management Drugs & Devices Price by Manufacturers
  • 3.4 Pain Management Drugs & Devices Manufacturing Base Distribution, Product Types
    • 3.4.1 Pain Management Drugs & Devices Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pain Management Drugs & Devices Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pain Management Drugs & Devices Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Pain Management Drugs & Devices Market Size by Type (2015-2020)
    • 4.1.1 Global Pain Management Drugs & Devices Sales by Type (2015-2020)
    • 4.1.2 Global Pain Management Drugs & Devices Revenue by Type (2015-2020)
    • 4.1.3 Pain Management Drugs & Devices Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pain Management Drugs & Devices Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pain Management Drugs & Devices Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pain Management Drugs & Devices Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pain Management Drugs & Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pain Management Drugs & Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Pain Management Drugs & Devices Market Size by Application (2015-2020)
    • 5.1.1 Global Pain Management Drugs & Devices Sales by Application (2015-2020)
    • 5.1.2 Global Pain Management Drugs & Devices Revenue by Application (2015-2020)
    • 5.1.3 Pain Management Drugs & Devices Price by Application (2015-2020)
  • 5.2 Pain Management Drugs & Devices Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pain Management Drugs & Devices Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pain Management Drugs & Devices Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pain Management Drugs & Devices Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Pain Management Drugs & Devices by Country
    • 6.1.1 North America Pain Management Drugs & Devices Sales by Country
    • 6.1.2 North America Pain Management Drugs & Devices Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Pain Management Drugs & Devices Market Facts & Figures by Type
  • 6.3 North America Pain Management Drugs & Devices Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Pain Management Drugs & Devices by Country
    • 7.1.1 Europe Pain Management Drugs & Devices Sales by Country
    • 7.1.2 Europe Pain Management Drugs & Devices Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Pain Management Drugs & Devices Market Facts & Figures by Type
  • 7.3 Europe Pain Management Drugs & Devices Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Pain Management Drugs & Devices by Region
    • 8.1.1 Asia Pacific Pain Management Drugs & Devices Sales by Region
    • 8.1.2 Asia Pacific Pain Management Drugs & Devices Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Pain Management Drugs & Devices Market Facts & Figures by Type
  • 8.3 Asia Pacific Pain Management Drugs & Devices Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Pain Management Drugs & Devices by Country
    • 9.1.1 Latin America Pain Management Drugs & Devices Sales by Country
    • 9.1.2 Latin America Pain Management Drugs & Devices Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Pain Management Drugs & Devices Market Facts & Figures by Type
  • 9.3 Central & South America Pain Management Drugs & Devices Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Pain Management Drugs & Devices by Country
    • 10.1.1 Middle East and Africa Pain Management Drugs & Devices Sales by Country
    • 10.1.2 Middle East and Africa Pain Management Drugs & Devices Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Pain Management Drugs & Devices Market Facts & Figures by Type
  • 10.3 Middle East and Africa Pain Management Drugs & Devices Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abbvie Inc.
    • 11.1.1 Abbvie Inc. Corporation Information
    • 11.1.2 Abbvie Inc. Description, Business Overview and Total Revenue
    • 11.1.3 Abbvie Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbvie Inc. Pain Management Drugs & Devices Products Offered
    • 11.1.5 Abbvie Inc. Recent Development
  • 11.2 Astrazeneca Depomed Inc.
    • 11.2.1 Astrazeneca Depomed Inc. Corporation Information
    • 11.2.2 Astrazeneca Depomed Inc. Description, Business Overview and Total Revenue
    • 11.2.3 Astrazeneca Depomed Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Products Offered
    • 11.2.5 Astrazeneca Depomed Inc. Recent Development
  • 11.3 Djo Global Inc.
    • 11.3.1 Djo Global Inc. Corporation Information
    • 11.3.2 Djo Global Inc. Description, Business Overview and Total Revenue
    • 11.3.3 Djo Global Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Djo Global Inc. Pain Management Drugs & Devices Products Offered
    • 11.3.5 Djo Global Inc. Recent Development
  • 11.4 Eli Lilly & Co.
    • 11.4.1 Eli Lilly & Co. Corporation Information
    • 11.4.2 Eli Lilly & Co. Description, Business Overview and Total Revenue
    • 11.4.3 Eli Lilly & Co. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Products Offered
    • 11.4.5 Eli Lilly & Co. Recent Development
  • 11.5 Endo International
    • 11.5.1 Endo International Corporation Information
    • 11.5.2 Endo International Description, Business Overview and Total Revenue
    • 11.5.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Endo International Pain Management Drugs & Devices Products Offered
    • 11.5.5 Endo International Recent Development
  • 11.6 Glaxosmithkline
    • 11.6.1 Glaxosmithkline Corporation Information
    • 11.6.2 Glaxosmithkline Description, Business Overview and Total Revenue
    • 11.6.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Glaxosmithkline Pain Management Drugs & Devices Products Offered
    • 11.6.5 Glaxosmithkline Recent Development
  • 11.7 Hisamitsu Pharmaceutical Co. Inc.
    • 11.7.1 Hisamitsu Pharmaceutical Co. Inc. Corporation Information
    • 11.7.2 Hisamitsu Pharmaceutical Co. Inc. Description, Business Overview and Total Revenue
    • 11.7.3 Hisamitsu Pharmaceutical Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Products Offered
    • 11.7.5 Hisamitsu Pharmaceutical Co. Inc. Recent Development
  • 11.8 Johnson & Johnson
    • 11.8.1 Johnson & Johnson Corporation Information
    • 11.8.2 Johnson & Johnson Description, Business Overview and Total Revenue
    • 11.8.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Johnson & Johnson Pain Management Drugs & Devices Products Offered
    • 11.8.5 Johnson & Johnson Recent Development
  • 11.9 Medtronic Inc.
    • 11.9.1 Medtronic Inc. Corporation Information
    • 11.9.2 Medtronic Inc. Description, Business Overview and Total Revenue
    • 11.9.3 Medtronic Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Medtronic Inc. Pain Management Drugs & Devices Products Offered
    • 11.9.5 Medtronic Inc. Recent Development
  • 11.10 Novartis International Ag
    • 11.10.1 Novartis International Ag Corporation Information
    • 11.10.2 Novartis International Ag Description, Business Overview and Total Revenue
    • 11.10.3 Novartis International Ag Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Novartis International Ag Pain Management Drugs & Devices Products Offered
    • 11.10.5 Novartis International Ag Recent Development
  • 11.1 Abbvie Inc.
    • 11.1.1 Abbvie Inc. Corporation Information
    • 11.1.2 Abbvie Inc. Description, Business Overview and Total Revenue
    • 11.1.3 Abbvie Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbvie Inc. Pain Management Drugs & Devices Products Offered
    • 11.1.5 Abbvie Inc. Recent Development
  • 11.12 Purdue Pharmaceuticals Lp
    • 11.12.1 Purdue Pharmaceuticals Lp Corporation Information
    • 11.12.2 Purdue Pharmaceuticals Lp Description, Business Overview and Total Revenue
    • 11.12.3 Purdue Pharmaceuticals Lp Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Purdue Pharmaceuticals Lp Products Offered
    • 11.12.5 Purdue Pharmaceuticals Lp Recent Development
  • 11.13 Abbott
    • 11.13.1 Abbott Corporation Information
    • 11.13.2 Abbott Description, Business Overview and Total Revenue
    • 11.13.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Abbott Products Offered
    • 11.13.5 Abbott Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Pain Management Drugs & Devices Market Estimates and Projections by Region
    • 12.1.1 Global Pain Management Drugs & Devices Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Pain Management Drugs & Devices Revenue Forecast by Regions 2021-2026
  • 12.2 North America Pain Management Drugs & Devices Market Size Forecast (2021-2026)
    • 12.2.1 North America: Pain Management Drugs & Devices Sales Forecast (2021-2026)
    • 12.2.2 North America: Pain Management Drugs & Devices Revenue Forecast (2021-2026)
    • 12.2.3 North America: Pain Management Drugs & Devices Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Pain Management Drugs & Devices Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Pain Management Drugs & Devices Sales Forecast (2021-2026)
    • 12.3.2 Europe: Pain Management Drugs & Devices Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Pain Management Drugs & Devices Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Pain Management Drugs & Devices Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Pain Management Drugs & Devices Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Pain Management Drugs & Devices Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Pain Management Drugs & Devices Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Pain Management Drugs & Devices Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Pain Management Drugs & Devices Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Pain Management Drugs & Devices Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Pain Management Drugs & Devices Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Pain Management Drugs & Devices Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Pain Management Drugs & Devices Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Pain Management Drugs & Devices Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Pain Management Drugs & Devices Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Pain Management Drugs & Devices Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pain Management Drugs & Devices Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Pain Management Drugs & Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pain Management Drugs & Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Pain Management Drugs & Devices market is segmented into
    Pharmaceuticals
    Devices

    Segment by Application, the Pain Management Drugs & Devices market is segmented into
    Burn Pain
    Cancer Pain
    Dental/Facial Pain
    Migraine Headache Pain
    Musculoskeletal Pain
    Neuropathic Pain
    Obstetrical Pain

    Regional and Country-level Analysis
    The Pain Management Drugs & Devices market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pain Management Drugs & Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Pain Management Drugs & Devices Market Share Analysis
    Pain Management Drugs & Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pain Management Drugs & Devices business, the date to enter into the Pain Management Drugs & Devices market, Pain Management Drugs & Devices product introduction, recent developments, etc.
    The major vendors covered:
    Abbvie Inc.
    Astrazeneca Depomed Inc.
    Djo Global Inc.
    Eli Lilly & Co.
    Endo International
    Glaxosmithkline
    Hisamitsu Pharmaceutical Co. Inc.
    Johnson & Johnson
    Medtronic Inc.
    Novartis International Ag
    Pfizer
    Purdue Pharmaceuticals Lp
    Abbott


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Pain Management Drugs & Devices. Industry analysis & Market Report on COVID-19 Impact on Global Pain Management Drugs & Devices is a syndicated market report, published as COVID-19 Impact on Global Pain Management Drugs & Devices, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Pain Management Drugs & Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,093.05
    4,639.57
    6,186.09
    3,452.88
    5,179.33
    6,905.77
    416,785.20
    625,177.80
    833,570.40
    293,292.48
    439,938.72
    586,584.96
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report